4
Changes in Ownership
Foghorn Therapeutics Inc. Filed Acc 0001073385-26-000004
Options or other derivatives
- Director acquired 28,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| PARSHALL B LYNNE Director | 2026-06-24 | Grant or award · Stock Options (Right to buy) | +28,000 | $4.08 | $114,240 | 28,000 | D |
Loading xslF345X06/primarydocument.xml…